HN2003000080A - Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso - Google Patents

Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso

Info

Publication number
HN2003000080A
HN2003000080A HN2003000080A HN2003000080A HN2003000080A HN 2003000080 A HN2003000080 A HN 2003000080A HN 2003000080 A HN2003000080 A HN 2003000080A HN 2003000080 A HN2003000080 A HN 2003000080A HN 2003000080 A HN2003000080 A HN 2003000080A
Authority
HN
Honduras
Prior art keywords
useful
tienopiridins
antiangiogen
indolil
procedures
Prior art date
Application number
HN2003000080A
Other languages
English (en)
Inventor
Robert Steven Kania
William Henry Romines Iii
Stephan James Cripps
Mingying He
Jihong Lou
Ru Zhou
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HN2003000080A publication Critical patent/HN2003000080A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVAS TIENOPIRIDINAS Y DERIVADOS DE TIENOPIRIDINA QUE SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS TALES COMO CANCERES, EN MAMIFEROS.
HN2003000080A 2002-03-01 2003-02-27 Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso HN2003000080A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36095202P 2002-03-01 2002-03-01

Publications (1)

Publication Number Publication Date
HN2003000080A true HN2003000080A (es) 2004-05-05

Family

ID=27789048

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2003000080A HN2003000080A (es) 2002-03-01 2003-02-27 Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso

Country Status (15)

Country Link
US (1) US6833456B2 (es)
EP (1) EP1483268A2 (es)
JP (1) JP2005527511A (es)
AR (1) AR040398A1 (es)
AU (1) AU2003206068A1 (es)
BR (1) BR0308162A (es)
CA (1) CA2478050A1 (es)
GT (1) GT200300046A (es)
HN (1) HN2003000080A (es)
MX (1) MXPA04008403A (es)
PA (1) PA8568101A1 (es)
PE (1) PE20030944A1 (es)
TW (1) TW200306193A (es)
UY (1) UY27685A1 (es)
WO (1) WO2003074529A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77303C2 (en) 2002-06-14 2006-11-15 Pfizer Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
AU2008202205B2 (en) * 2003-12-23 2009-09-10 Pfizer Inc. Novel quinoline derivatives
SG141459A1 (en) * 2003-12-23 2008-04-28 Pfizer Novel quinoline derivatives
JPWO2005066124A1 (ja) * 2003-12-26 2007-12-20 第一三共株式会社 ピロリジン誘導体の製造法
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
MX2007001216A (es) 2004-07-30 2007-03-23 Methylgene Inc Inhibidores de la senalizacion del receptor del factor de crecimiento endotelial vascular y del receptor del factor de crecimiento del hepatocito.
US8093264B2 (en) 2005-05-20 2012-01-10 Methylgene Inc. Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling
DK1904504T3 (da) * 2005-05-20 2014-06-23 Methylgene Inc Inhibitorer af vegf-receptor- og hgf-receptorsignalering
EP1915368A1 (en) 2005-08-08 2008-04-30 Pfizer, Inc. Salts and polymorphs of a vergf-r inhibitor
CA2636242A1 (en) * 2006-01-30 2008-05-29 Array Biopharma, Inc. Heterobicyclic thiophene compounds and methods of use
AR060061A1 (es) * 2006-03-22 2008-05-21 Methylgene Inc Inhibidores de la actividad de la proteina tirosina quinasa
US20110053931A1 (en) * 2006-06-08 2011-03-03 John Gaudino Quinoline compounds and methods of use
AU2009221583B2 (en) 2008-03-05 2013-06-20 Methylgene Inc. Inhibitors of protein tyrosine kinase activity
KR101126736B1 (ko) * 2008-11-27 2012-04-12 주식회사 레고켐 바이오사이언스 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물
EP2606035B1 (en) * 2010-07-29 2017-09-06 BIAL - Portela & CA., S.A. Proces for the synthesis of substituted urea compounds
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AU2014359456B2 (en) 2013-12-04 2019-01-24 Evotec International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
KR20160142401A (ko) 2014-04-25 2016-12-12 화이자 인코포레이티드 도파민 d1 리간드로서 헤테로방향족 화합물 및 이의 용도
CN115746017B (zh) * 2022-11-30 2024-06-07 英维沃化工科技(广州)有限公司 一种噻吩并嘧啶类化合物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
US6177401B1 (en) 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
JP2890267B2 (ja) 1994-02-23 1999-05-10 ファイザー インク． ４−ヘテロサイクリル−置換キナゾリン誘導体、その調製法および抗癌剤としてのその使用法
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
DE122005000053I2 (de) 1995-03-30 2008-01-17 Pfizer Prod Inc Chinazolinderivate
JP3053222B2 (ja) 1995-04-20 2000-06-19 ファイザー・インコーポレーテッド Ｍｍｐおよびｔｎｆ抑制剤としてのアリールスルホニルヒドロキサム酸誘導体
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
MX9709867A (es) 1995-06-07 1998-03-31 Pfizer Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos.
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
AU719327B2 (en) 1996-03-05 2000-05-04 Astrazeneca Ab 4-anilinoquinazoline derivatives
ES2249800T3 (es) 1996-06-24 2006-04-01 Pfizer Inc. Derivados triciclicos sustituidos con fenilamino para el tratamento de enfermedades hiperproliferativas.
US6071935A (en) * 1996-06-27 2000-06-06 Pfizer Inc. Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
ID19430A (id) 1996-07-13 1998-07-09 Glaxo Group Ltd Senyawa senyawa heterosiklik
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
DE69712496T2 (de) 1996-07-18 2002-08-29 Pfizer Inc., New York Matrix metalloprotease-inhibitoren auf basis von phosphinsäuren
IL128189A0 (en) 1996-08-23 1999-11-30 Pfizer Arylsulfonylamino hydroxamic acid derivatives
WO1998023613A1 (en) 1996-11-27 1998-06-04 Pfizer Inc. Fused bicyclic pyrimidine derivatives
EP0950059B1 (en) 1997-01-06 2004-08-04 Pfizer Inc. Cyclic sulfone derivatives
ID22799A (id) 1997-02-03 1999-12-09 Pfizer Prod Inc Turunan-turunan asam arilsulfonilamino hidroksamat
BR9807824A (pt) 1997-02-07 2000-03-08 Pfizer Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz
ID22809A (id) 1997-02-11 1999-12-09 Pfizer Turunan-turunan asam arilsulfonil hidroksamat
AU734009B2 (en) 1997-05-30 2001-05-31 Merck & Co., Inc. Novel angiogenesis inhibitors
WO1999010349A1 (en) 1997-08-22 1999-03-04 Zeneca Limited Oxindolylquinazoline derivatives as angiogenesis inhibitors
WO1999016755A1 (en) 1997-09-26 1999-04-08 Merck & Co., Inc. Novel angiogenesis inhibitors
PA8469501A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico
EP2020408B1 (en) 1998-05-29 2013-06-26 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitor
JP2002533404A (ja) 1998-12-23 2002-10-08 ジー・ディー・サール・アンド・カンパニー 新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
PT1287001E (pt) * 2000-06-06 2004-12-31 Pfizer Prod Inc Derivados de tiofeno uteis como agentes anticancerigenos
AU2002345792A1 (en) * 2001-06-21 2003-01-08 Pfizer Inc. Thienopyridine and thienopyrimidine anticancer agents

Also Published As

Publication number Publication date
UY27685A1 (es) 2003-10-31
WO2003074529A2 (en) 2003-09-12
PE20030944A1 (es) 2003-11-08
US20040019065A1 (en) 2004-01-29
AU2003206068A1 (en) 2003-09-16
WO2003074529A3 (en) 2003-12-24
TW200306193A (en) 2003-11-16
AU2003206068A8 (en) 2003-09-16
AR040398A1 (es) 2005-04-06
MXPA04008403A (es) 2004-11-26
CA2478050A1 (en) 2003-09-12
PA8568101A1 (es) 2003-11-12
JP2005527511A (ja) 2005-09-15
US6833456B2 (en) 2004-12-21
GT200300046A (es) 2003-10-10
BR0308162A (pt) 2004-12-07
EP1483268A2 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
HN2003000080A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
HN2003000182A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metodo para su uso
HN2003000416A (es) Derivados de pirrolopirimidina
HN2007015177A (es) Derivados de triazolopirazina
CR8919A (es) Analogos de tetrapeptidos
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
HN1999000080A (es) Derivados de isotiazol utiles como agentes anticancerosos.
PA8600601A1 (es) Ligandos de receptores de cannabinoides y sus usos
CR9014A (es) Novedosos derivados de heteroarilsulfamida benzofusionados como agentes anticonvulsionantes
HN2003000257A (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos.
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
ECSP067120A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
UY33616A (es) Compuestos con estructura de imidazotriazinona
CL2011003346A1 (es) Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente.
HN2003000422A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
ITMI20052171A1 (it) Composti e-amminocarbonil bicicloepten pirimidindiamminici stereoisomericamente arricchiti e loro uso
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
SV2006002283A (es) Formulaciones
HN2004000146A (es) Dihidroquinazolinas sustituidas
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
UY30052A1 (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
CR8288A (es) 6-[ (sustituido) fenil] triazolopirimidinas como agentes anticancer
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
UY29417A1 (es) Agentes endoparasiticidas